Heilmann, Thorsten, Vondung, Florian, Borzikowsky, Christoph ORCID: 0000-0002-5489-0032, Szymczak, Silke ORCID: 0000-0002-8897-9035, Krueger, Sandra, Alkatout, Ibrahim, Wenners, Antonia, Bauer, Maret, Klapper, Wolfram, Roecken, Christoph, Maass, Nicolai, von Karstedt, Silvia, Schem, Christian and Trauzold, Anna (2019). Heterogeneous intracellular TRAIL-receptor distribution predicts poor outcome in breast cancer patients. J. Mol. Med., 97 (8). S. 1155 - 1168. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1440

Full text not available from this repository.

Abstract

Upon ligand binding, plasma membrane-located TNF-related apoptosis-inducing ligand (TRAIL)-receptors 1 and 2 induce apoptosis as well as cancer-promoting signaling in cancer cells. TRAIL-R3 and TRAIL-R4 are believed to negatively regulate TRAIL-mediated apoptosis. Intracellular localization of TRAIL-receptors, as observed in many tumor cells, has been associated with oncogenic features, which are distinct from membrane-associated TRAIL-R signaling. Here, analyzing a panel of 354 breast cancer specimens, we found that an unfavorable outcome correlating with cancer-promoting properties of TRAIL-R1, TRAIL-R2, and TRAIL-R4 was most significantly defined by their intracellular distribution and mutual co-expression. A nuclear or cytoplasmic heterogeneous expression pattern correlated with markedly decreased overall survival and discriminated high-risk breast cancer patients from low-risk patients with a homogeneous distribution of expression, i.e., nuclear and cytoplasmic expression. The homogeneous TRAIL-R expression was associated with favorable breast cancer surrogate markers corresponding with excellent survival prognoses at 5years after diagnosis (hazard ratio, 0.043) and over the complete course of follow-up (hazard ratio, 0.098; both p<0.001). No associations with specific intrinsic breast cancer subtypes were found. Our data suggest that the determination of intracellular co-expression patterns of TRAIL-R1, TRAIL-R2, and TRAIL-R4 provides an innovative and robust method for risk stratification in breast cancer patients beyond conventional prognostic markers.Key messagesA total of 70% of breast cancer specimens show comparably high levels of intracellular TRAIL-Rs.Nuclear or cytoplasmic TRAIL-R co-expression occurs in the majority of tumors.A total of 25% of tumors show a heterogeneous expression of cytoplasmic or nuclear TRAIL-Rs.Patients with a heterogeneous TRAIL-R expression present with poor prognoses.Additive TRAIL-R-based risk stratification comprises different breast cancer subtypes.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Heilmann, ThorstenUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Vondung, FlorianUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Borzikowsky, ChristophUNSPECIFIEDorcid.org/0000-0002-5489-0032UNSPECIFIED
Szymczak, SilkeUNSPECIFIEDorcid.org/0000-0002-8897-9035UNSPECIFIED
Krueger, SandraUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Alkatout, IbrahimUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Wenners, AntoniaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Bauer, MaretUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Klapper, WolframUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Roecken, ChristophUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Maass, NicolaiUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
von Karstedt, SilviaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schem, ChristianUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Trauzold, AnnaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-134085
DOI: 10.1007/s00109-019-01805-w
Journal or Publication Title: J. Mol. Med.
Volume: 97
Number: 8
Page Range: S. 1155 - 1168
Date: 2019
Publisher: SPRINGER HEIDELBERG
Place of Publication: HEIDELBERG
ISSN: 1432-1440
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
DEATH RECEPTORS; PROGNOSTIC VALUE; LIGAND TRAIL; APOPTOSIS; EXPRESSION; CELLS; ENDOCYTOSIS; METASTASIS; RESISTANCE; SURVIVALMultiple languages
Genetics & Heredity; Medicine, Research & ExperimentalMultiple languages
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/13408

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item